General Flashcards
7 cards from real MPJE practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 General flashcards as text
Under the Combat Methamphetamine Epidemic Act, the daily purchase limit for pseudoephedrine is:
Answer: 3.6 grams
CMEA limits pseudoephedrine purchases to 3.6 grams per day and 9 grams per 30-day period.
A pharmacist who breaches patient confidentiality without authorization may face disciplinary action under:
Answer: State pharmacy practice acts and HIPAA
Unauthorized disclosure of patient information can trigger both state pharmacy board sanctions and federal HIPAA penalties.
Which of the following best defines 'adulteration' of a drug product under the FD&C Act?
Answer: A product that fails to meet established quality, strength, or purity standards
Under the FD&C Act, adulteration refers to a drug that does not meet quality, strength, purity, or composition standards.
A pharmacist may dispense a Schedule III controlled substance refill up to how many times within 6 months of the original prescription date?
Answer: Up to 5 times
Schedule III and IV controlled substances may be refilled up to 5 times within 6 months of the original issue date.
Under the Poison Prevention Packaging Act, child-resistant containers are NOT required for which of the following?
Answer: Nitroglycerin sublingual tablets
Nitroglycerin sublingual tablets are specifically exempt from PPPA child-resistant packaging requirements.
The 'corresponding responsibility' doctrine under federal controlled substance law holds that:
Answer: A pharmacist shares responsibility for ensuring a controlled substance prescription is issued for a legitimate medical purpose
Corresponding responsibility means a pharmacist who knowingly fills an illegitimate controlled substance prescription shares legal liability with the prescriber.
A pharmacy that compounds sterile preparations for office use by practitioners must comply with which USP chapter?
Answer: USP
USP establishes standards for sterile compounding to minimize risks of contamination, infection, and other harm.